Impact of biologic class and treatment line on psoriatic arthritis risk in psoriasis: a population-based cohort study
Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence suggests that biologic therapies may differentially influence the development of PsA; however, there are no data on the relative ability of second-line biological therapy to prev...
Збережено в:
| Автори: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMJ Publishing Group
2026-05-01
|
| Серія: | RMD Open |
| Онлайн доступ: | https://rmdopen.bmj.com/content/12/2/e006687.full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|